Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Asensus Surgical Inc (ASXC)

Asensus Surgical Inc (ASXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 440,529
  • Shares Outstanding, K 234,324
  • Annual Sales, $ 3,180 K
  • Annual Income, $ -59,310 K
  • 60-Month Beta 1.50
  • Price/Sales 134.32
  • Price/Cash Flow N/A
  • Price/Book 2.68
Trade ASXC with:

Options Overview Details

View History
  • Implied Volatility 98.29%
  • Historical Volatility 52.79%
  • IV Percentile 3%
  • IV Rank 4.87%
  • IV High 182.67% on 03/11/21
  • IV Low 93.97% on 09/08/21
  • Put/Call Vol Ratio 0.38
  • Today's Volume 1,455
  • Volume Avg (30-Day) 1,356
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 56,969
  • Open Int (30-Day) 64,806

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8000 +8.33%
on 09/20/21
2.3700 -17.72%
on 09/02/21
-0.1700 (-8.02%)
since 08/20/21
3-Month
1.8000 +8.33%
on 09/20/21
3.5983 -45.81%
on 06/28/21
-1.2100 (-38.29%)
since 06/22/21
52-Week
0.3344 +483.13%
on 09/25/20
6.9500 -71.94%
on 02/10/21
+1.6036 (+462.93%)
since 09/22/20

Most Recent Stories

More News
Asensus Surgical (ASXC) Reports Q2 Loss, Misses Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 16.67% and -32.39%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

ASXC : 1.9450 (+3.46%)
Will Asensus Surgical (ASXC) Report Negative Earnings Next Week? What You Should Know

Asensus Surgical (ASXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ASXC : 1.9450 (+3.46%)
Surgalign vs. Asensus Surgical: Which Medical Equipment Stock is a Better Buy?

The medical equipment industry has been growing at a healthy clip this year, with rising demand for elective surgeries that had been on hold during the worst of the COVID-19 pandemic last year. So, two...

SRGA : 1.3200 (-1.49%)
ASXC : 1.9450 (+3.46%)
Abbott (ABT) Downgrades 2021 Outlook on Lower Testing Demand

Abbott's (ABT) revised 2021 forecast continues to reflect strong, double-digit EPS growth despite lower COVID-19 testing demand.

COO : 434.44 (+1.80%)
ABT : 124.81 (-0.26%)
NVST : 41.70 (+1.58%)
ASXC : 1.9450 (+3.46%)
Myriad Genetics (MYGN) Sells myPath to Focus on Core Units

Myriad Genetics' (MYGN) new divesture will provide the company with growth capital for future investments.

COO : 434.44 (+1.80%)
MYGN : 34.48 (+1.44%)
LH : 291.53 (-0.89%)
ASXC : 1.9450 (+3.46%)
Quest Diagnostics (DGX) Buys Outreach Lab, Widens Midwest Base

Mercy's outreach laboratory services are set to get integrated into Quest Diagnostics' (DGX) full-service laboratory in Lenexa, KS.

DGX : 152.58 (-1.14%)
COO : 434.44 (+1.80%)
NVST : 41.70 (+1.58%)
ASXC : 1.9450 (+3.46%)
Here's Why You Should Add STERIS (STE) to Your Portfolio

Investors are optimistic about STERIS (STE) owing to strong segmental performance and huge growth potential in healthcare and pharmaceutical industries.

COO : 434.44 (+1.80%)
STE : 216.00 (+1.83%)
NVST : 41.70 (+1.58%)
ASXC : 1.9450 (+3.46%)
Cocrystal Pharma Announces the Passing of Chairman, CEO and Co-founder Dr. Gary Wilcox

With great sadness, Cocrystal Pharma, Inc. (Nasdaq: COCP), ("Cocrystal" or the "Company") announces that Gary Wilcox, Ph.D., Chairman, CEO and co-founder, suddenly passed away Wednesday, May 26 at the...

COCP : 1.0250 (-2.38%)
OPK : 3.80 (-0.52%)
GPX : 20.68 (+0.15%)
ASXC : 1.9450 (+3.46%)
Thinking about buying stock in SOS, GameStop, New Oriental Education, Asensus Surgical, or Nabriva Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SOS, GME, EDU, ASXC, and NBRV.

ASXC : 1.9450 (+3.46%)
NBRV : 1.1852 (+4.88%)
EDU : 1.9950 (+5.00%)
GME : 190.92 (+0.51%)
SOS : 2.42 (+1.68%)
The Autism Spectrum Disorders (ASD) Market Is Projected To Reach $4.53 Billion By 2026

, /PRNewswire/ -- Autism spectrum disorder (ASD) represents a group of neurodevelopmental disorders or disabilities; it is a heritable and a polygenic disorder. Autism spectrum disorder is lifelong and...

GWHP : 0.3000 (+0.33%)
SYBX : 3.52 (-1.40%)
ADMS : 4.78 (-2.05%)
MNKD : 4.66 (+1.75%)
UTHR : 201.98 (+1.58%)
ASXC : 1.9450 (+3.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Asensus Surgical Inc. is a medical device company which is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM). Asensus Surgical Inc., formerly known as TransEnterix Inc., is based in RESEARCH TRIANGLE PARK, N.C.

See More

Key Turning Points

3rd Resistance Point 2.0267
2nd Resistance Point 1.9733
1st Resistance Point 1.9267
Last Price 1.9450
1st Support Level 1.8267
2nd Support Level 1.7733
3rd Support Level 1.7267

See More

52-Week High 6.9500
Fibonacci 61.8% 4.4228
Fibonacci 50% 3.6422
Fibonacci 38.2% 2.8616
Last Price 1.9450
52-Week Low 0.3344

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar